Search Weight Loss Topics:

Page 434«..1020..433434435436..440450..»

Deprescribe the world! New study shows low-carb diets would save BILLIONS currently wasted on drugs. But will Big Pharma allow it? – RT

Posted: November 3, 2020 at 8:59 am

The work of a British family doctor demonstrates that stopping eating carbohydrates helps with blood pressure, diabetes and weight loss - helping save lives during Covid-19. But the medical industry doesnt want you to know this.

If you want to avoid dying of Covid-19, one of the most important things you can do, if you are overweight, is to shed the pounds

A recent study by an international team of researchers using data from 399,000 patients found that people with obesity who contracted coronavirus were 113 percent more likely than people of healthy weight to end up in hospital, 74 percent more likely to be admitted to intensive care, and 48 percent more likely to die.

Why? Well, the why centres around the damaging effect of raised blood glucose on endothelial cells and it gets complicated.

The most important thing is not to understand the complex metabolic and physiological pathways involved, but simply to help people to lose weight, and this is where Dr. David Unwin comes in.

For years, this family doctor from Southport, in northwest England, has believed, as I do, that the main driver of weight gain, eventually leading on to type 2 diabetes, is a high-carbohydrate diet. That means consuming too much pasta, potatoes, rice, bread, processed sugar, and so on, and not enough red meat, olive oil, butter, eggs, and the like.

This, of course, is exactly the opposite of what we have been told for decades by the experts who demonise fat and promote carbohydrates. We have the eat-well plate, and the food pyramid, and hundreds of thousands of dieticians around the world, all promoting carbohydrates as the healthy option.

Dutifully following this advice, the entire population of the Western world has become fatter, and fatter and fatter. And more and more unhealthy. By the way, this is not a coincidence; it is cause and effect.

But getting back to Dr. Unwin years ago, he despaired of ever getting any of his patients to lose weight. It was so disheartening, he furtively studied his pension plan and dreamed of retirement. Then, one day, a patient came in to his surgery who had lost a lot of weight and kept it off.

At first, this woman was reluctant to say how she had done it, as she feared the inevitable criticism. In the end, however, she confessed to Dr. Unwin that she had achieved it by eating a low-carbohydrate diet. In Dr. Unwins own words:

I was interested to find out how the patient had improved her diabetic control. She confessed she had ignored my advice and learnt a much better way to look after herself from the internet. I suppressed my wounded pride and looked at the low-carb forum on diabetes.co.uk. There were thousands of type 2 diabetics on there ignoring their doctors and getting great results ([but] now that is just not allowed).

The GP did not criticise his patient; instead, he was intrigued. Could this possibly be true? It went against everything he had been told about healthy eating, weight loss, and type 2 diabetes fat has twice the calories per gram as carbohydrates and suchlike. Eating fat, hed been programmed to believe, makes you fat, and then you develop diabetes and heart disease.

Dr. Unwin did more research, then made the decision to work with his patients, mainly those with diabetes, to see if a low-carbohydrate diet could be beneficial. Lo and behold, it was very beneficial. In fact, it was like a miracle cure.

In 2014, he published a paper on his results on a small number of patients. It stated:

It was observed that a low-carbohydrate diet achieved substantial weight loss in all patients and brought about normalisation of blood glucose control in 16 out of 18 patients. At the same time, plasma lipid profiles improved, and BP [blood pressure] fell, allowing discontinuation of antihypertensive therapy in some individuals

Conclusions: Based on our work so far, we can understand the reasons for the internet enthusiasm for a low-carbohydrate diet: the majority of patients lose weight rapidly and fairly easily [and,] predictably, the HbA1c levels are not far behind. Cholesterol levels, liver enzymes, and BP levels all improved. This approach is simple to implement and much appreciated by people with diabetes.

Now, he has published results of a much larger study, of nearly 200 patients over a six-year period, which has just been published in the British Medical Journals Nutrition, Prevention & Health.

Its main findings make an impressive case for the low-carb diet and how it can lead to people being much healthier and getting off lifelong medication:

46 percent drug-free Type 2 diabetes remission.

Significant improvements in weight, blood pressure, and lipid profiles.

93 percent remission of prediabetes.

Four individuals came off insulin altogether.

Total weight loss for the 199 participants was 1.6 metric ton.

50,885 annual savings in the practices diabetes-drug budget.

If every GP practice adopted the practice, the NHS could save c. 277 million (c.$350 million) a year

This paper will be attacked, of course, as there are massive financial interests involved here. The savings that the NHS could achieve would be dwarfed if the US, with its much higher drugs costs, adopted the policies: we could be looking at around $2 billion a year. Around the world, who knows, but it would be vast sums of money.

So, you can imagine the joy that this paper will be met with in pharmaceutical company boardrooms around the world. The words lead and balloon, spring to mind. Equally, the massive low-fat high-carb food manufacturers will be throwing their hands up in horror My bonus, my bonus! Nooooo! You can take all your low-carb yoghurts and

As for the rest of us, I can assure you that Dr. Unwin has only ever been interested in one thing: working out how to help people lose weight and control their diabetes. He has achieved this for his patients and is showing the rest of the world how to do the same.

Will his research now be taken up by the authorities around the world? Will we move away from promoting a high-carbohydrate diet? You have to be joking. There is far too much money to be lost by the companies who exert tight control over the world of medical research, and whose lobbyists swarm around politicians in rich countries.

Which is a damn shame, because more than ever in this endless Covid-19 pandemic, obesity represents a health crisis. This paper, and the tireless work by Dr Unwin, clearly tells us what we need to do now, urgently. If Boris Johnson is serious about his plan for the nation to get slimmer and fitter, he himself should go on a low-carb diet and extol its virtues.

Dr Unwins approach wont work instantly, and it wont work for everyone nothing ever does. However, it represents hope. It could save hundreds and thousands of lives. Perhaps more than any vaccine. His research should be shouted from the rooftops.

Think your friends would be interested? Share this story!

The statements, views and opinions expressed in this column are solely those of the author and do not necessarily represent those of RT.

Go here to read the rest:
Deprescribe the world! New study shows low-carb diets would save BILLIONS currently wasted on drugs. But will Big Pharma allow it? - RT

Surprising Health Benefits Of Adding Garlic To Your Diet: You Must Know These! – Doctor NDTV

Posted: November 3, 2020 at 8:59 am

Garlic Health Benefits: These tiny cloves are beneficial in controlling several health conditions. Garlic has a strong flavour that can be added to a variety of foods and drinks. Read here to know some amazing health benefits.

Garlic contains anti-bacterial properties which can help reduce cold symptoms

Garlic is commonly used to enhance the flavour of food as well as drinks. This herb provides several health benefits to your body and overall health. Garlic contains manganese, selenium, fibre, copper, potassium, iron and vitamin B6 and C. These small cloves are also loaded with antioxidants and anti-bacterial properties. It is also beneficial for several health conditions like diabetes, high blood pressure and much more. Garlic can be added to your diet in several ways. Many consume fresh garlic cloves as first thing in the morning. You can also add chopped garlic as a topping on salads and different foods. Here are some notable health benefits of garlic you need to know.

Diabetes requires healthy management of blood sugar levels. A healthy and well-balanced diet can help you manage this condition. According to studies, raw garlic may help reduce blood sugar levels. You may seek advice from your doctor before adding garlic to your diabetes diet.

Adding garlic to diet can help reduce blood sugar levels, as per studiesPhoto Credit: iStock

Adding garlic to diet can help you boost heart health by reducing bad cholesterol. Bad cholesterol is deposited inside the arteries which restricts the free flow of blood throughout the body. Adding garlic to diet can fight bad cholesterol levels.

Also read:Here's How Garlic Is Beneficial For Your Heart Health; Know Ways To Add It To Your Diet

Garlic is anti-bacterial properties that can assist in reducing cold and flu symptoms. Sipping warm garlic tea can give you relief. You can boil crushed garlic cloves and some ginger in a cup of water and drink this tea after adding some honey to it. This remedy will reduce cold and flu symptoms.

Also read:Know How You Can Use The Herb For Better Heart Health And Stronger Immunity

Garlic contains properties which can help reduce cold symptomsPhoto Credit: iStock

Promoted

High blood pressure significantly increases the risk of heart disease. According to studies, garlic reduces blood pressure. Prepare a fiber-rich salad and add some chopped garlic to it. You can also add garlic to your soups and other recipes.

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.

Go here to see the original:
Surprising Health Benefits Of Adding Garlic To Your Diet: You Must Know These! - Doctor NDTV

Weight Loss and Diet Management Products and Services Market Size of Dynamics, Products, Application, Forecast Report 2020-2027 – Zenit News

Posted: November 3, 2020 at 8:59 am

According to Market Study Report, Weight Loss and Diet Management Products and Services Market provides a comprehensive analysis of the Weight Loss and Diet Management Products and Services Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry.

The Weight Loss and Diet Management Products and Services Market is projected to reach USD XX Billion by 2023 from USD XX Billion in 2018, at a CAGR of XX%. This report spread across 122 Pages, Profiling 10 Companies and Supported with 114 Tables and 24 figures are now available in this research.

Request Sample Report @ https://beathanreports.com/request-for-sample-report/13432

The Weight Loss and Diet Management Products and Services Market report is a compilation of first-hand information, qualitative and competitive assessment industry analysts, inputs from industry experts, and industry participants across the value chain. The research report market provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments, trending Key Factors, and geographies.

The following players are covered in this report:

AHD International

Atkins Nutritionals

Bio-Synergy

Body-Solid

Brunswick

Conagra Foods

Glaxosmithkline

Kellogg

Kraft Foods

Medifast

Nautilus

Nestle

Nutrasweet

Nutrisystem

Pepsico

Quaker Oats

Skinny Nutritional

Streamline Foods

Tate And Lyle

Coca-Cola

Hershey

Unilever

Vivus

Vlcc Group

Weight Watcher

Wellness International

Request Discount About This Report @ https://beathanreports.com/discount-request-on-report/13432

Growing popularity of soft adventure sports and increasing focus towards fitness are significant factors driving the growth of the Weight Loss and Diet Management Products and Services market. However, high cost of Weight Loss and Diet Management Products and Services might hinder the growth of the Weight Loss and Diet Management Products and Services market. The demand for Weight Loss and Diet Management Products and Services is high in North America and Europe region and the APAC is expected to grow at high CAGR which is creating lucrative business opportunities for the companies operating in the market.

MARKET SEGMENTATION

Breakdown Data by Type

Meals

Beverages

Supplements

Weight Loss and Diet Management Products and Services Breakdown Data by Application

Weight Loss Surgery

MDs

Hospitals/Clinic Programs

Rx Diet Drugs

Bariatricians

VLCD Programs

Based on regional and country-level analysis, the Weight Loss and Diet Management Products and Services market has been segmented as follows:

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Request For Customization About This Report @ https://beathanreports.com/request-for-customization/13432

This report provides a thorough analysis of the Weight Loss and Diet Management Products and Services market through detailed research on a variety of topics to help players build strong growth strategies and strong presence in the industry. Readers will also be informed of the important sustainability strategies adopted by leading companies when operating in the Weight Loss and Diet Management Products and Services market. The analyst also thoroughly evaluated the impact of these strategies on market growth and competition.

Chapter Details of Weight Loss and Diet Management Products and Services Market:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Weight Loss and Diet Management Products and Services Market Landscape

Part 04: Weight Loss and Diet Management Products and Services Market Sizing

Part 05: Weight Loss and Diet Management Products and Services Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Reason to access this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Weight Loss and Diet Management Products and Services market and its sub segments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies.

Contact Us

Beathan Report,

4004 W Lake Sammamish,

Pkway B9 Redmond,

WA 98052 United States.

Tel: +44 115 888 3028

Web: http://www.beathanreports.com

About Us

More:
Weight Loss and Diet Management Products and Services Market Size of Dynamics, Products, Application, Forecast Report 2020-2027 - Zenit News

Catering to the plant-based diet trend: What about the package? – Grocery Dive

Posted: November 3, 2020 at 8:59 am

The popularity of diets emphasizing predominantly plant-based foods has been growing for several years, and in 2020, it is a major market trend, gone mainstream. Consumers simply want to eat healthier and more sustainable foods. Grocery retailers are capitalizing on the movement, taking steps to meet shoppers latest preferences by offering greater varieties of more exotic produce, merchandising and promoting plant-based food options and cooking ideas.

At the same time, more people are ordering their groceries for home delivery, whether from a local store, a big e-commerce site, or a meal-kit subscription service. Often that decision is influenced by a desire to skip the store visit and opt for contactlessdelivery instead. Again, health concerns are driving consumer behavior and grocery shopping habits that extend to the packaging.

Corrugated has been around for 150 years, but it remains on trend today.Theres a tremendous backlash against single-use packaging particularly plastic and thats driven many in the supply chain to look more closely at corrugated.

Corrugated box manufacturers have been producing sustainable packaging for over a century paper-based, recyclable boxes that contain 50% recycled fiber on average, today. Boxes, themselves, are plant-based, made from trees grown in sustainable forests for the express purpose of becoming boxes. Those trees are planted by companies that harvest and re-plant new trees on a continuous basis. Theyre a renewable crop, just like the tomatoes and squash in a plant-based meal. With a harvest to planting ratio of 1 to 7 trees and a recovery rate of 92 percent, corrugated boxes are made to be remade using both new and recycled plant fibers.

Now more than ever, the food industry is positioned to build on the trust and partnership of being on the shoppers side, helping them achieve their dietary goals of eating well to stay as healthy as possible, said Dr. Hilary Thesmar, who oversees food safety and quality programs at FMI, according to Supply Chain Dive.

For many people, recent attention to personal and public health has sparked another look at the impact of our lifestyles on ourselves, on others and even on the planet we live on. Many of the people interested in plant-based and healthy diets are also concerned about sustainability and packaging. The Harvard Health Blog reportsthat Far from being separate issues, climate change and human health are two sides of the same coin. It is impossible to separate having a healthy body from having a healthy planet. Environmental health is human health.

Concerned citizens desire to reverse the tide of environmental destruction is not new. What has changed is that more people are paying more attention, between the pandemic and accumulating evidence that our way of life is having disastrous effects on the environment from climate change to plastics impacts on oceans, waterways and wildlife.

At the same time that we want to create less disposable waste, we also want to increase sanitary handling and behaviors.Contactlessdelivery options are important to consumers choosing to stay home more than they used to. They want to eat healthy, plant-based foods, and to have them delivered to their doorstep without having to interact with the public or store personnel.

In the spirit of values-based customer engagement, do not forget to consider how those groceries are delivered or displayed. Delivering healthy foods in sustainable, paper-based packaging sends a message: We get it.

For health-conscious consumers who care about sustainability, it only seems natural, to us, to put plant-based foods in a plant-based package.

Read this article:
Catering to the plant-based diet trend: What about the package? - Grocery Dive

Health Matters: Neurology and the Keto Diet – NBC2 News

Posted: November 3, 2020 at 8:59 am

Its high in fat, moderate in protein, and low in carbohydratesthe ketogenic diet is known for helping patients lose weight. But sleep medicine Dr. Jose Colon says, if done correctly, the diet can improve more than just your weight. Being on a ketogenic diet or being in a state of ketosis, has been shown to help with epilepsy and many other disorders as well, Dr. Jose Colon, a sleep medicine physician with Lee Health.

Doctors use the ketogenic diet to help treat patients with seizures. The ketogenic diet is very effective in epilepsy but its also been shown to be helpful in many other medical disorders, from weight loss to diabetes, type two diabetes, insulin resistance, it can help with PCOS, and it helps brain function from pediatric to geriatric, from autism to Alzheimers, he said.

The keto diet can also benefit patients who suffer from sleep disorders. Ive had several patients also have successful treatment of narcolepsy as well with the ketogenic diet. One of the things with narcolepsy is that your brain is in a sleepy state and high carbohydrate states turn off your alerting neurons so it can help with that disorder as well, said Dr. Colon.

Doctors can help patients successfully adapt and maintain a ketogenic diet. A lifestyle change that can benefit their overall health.

View More Health Matters video segments at LeeHealth.org/Healthmatters/

Lee Health in Fort Myers, FL is the largest network of health care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For more than 100 years, weve been providing our community with personalized preventative health services and primary care to highly specialized care services and robotic assisted surgeries. Lee Health Caring People. Inspiring Care.

Visit LeeHealth.org

Read the original post:
Health Matters: Neurology and the Keto Diet - NBC2 News

Global Testosterone Replacement Therapy Market 2020 Industry by Type, by Application, by Share, by Revenue and by Region Forecast to 2024 -…

Posted: November 3, 2020 at 8:58 am

Scope of the Report:

Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new Globalmarketers.biz Research study.

This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

To Understand How Covid-19 Impact on this industry. Get Free Sample Report:

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#request_sample

Global Testosterone Replacement Therapy report portrays the fundamental details of the dominant market players elaborating their business profiles, Testosterone Replacement Therapy market revenue, sales volume, press releases, technical developments taking place in this industry.

Report is segmented into different parts as below:

Global Testosterone Replacement Therapy Market Details Based On Key Players:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Global Testosterone Replacement Therapy Market Details Based on Product Category:

GelsInjectionsPatchesOther

Global Testosterone Replacement Therapy Market Details Based On Key Product Applications:

HospitalsClinicsOthers

Global Testosterone Replacement Therapy Market Details Based On Regions

Inquire Before Buying Or Ask For Custom Requirement:

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

The first part of the report portrays the information related to the basic Testosterone Replacement Therapy introduction, key market players, their company profiles, sales ratio, demand and supply volume, Testosterone Replacement Therapy market gains during 2018 and 2019. The second part of the Testosterone Replacement Therapy report extracts more details stating the sales revenue of each Testosterone Replacement Therapy industry player, the business strategies followed by them. The third part of the report displays the competitive scenario of all the Testosterone Replacement Therapy market players on basis of the revenue gains.

The fourth part of the report enlists the Testosterone Replacement Therapy details based on key producing regions and Testosterone Replacement Therapy market gains during the period from 2015 to 2019. Fifth, sixth, seventh, eighth and ninth part of the Testosterone Replacement Therapy report enlists the major countries within the regions and the Testosterone Replacement Therapy revenue generated during the period from 2012 to 2017. Tenth and eleventh part of the Testosterone Replacement Therapy report mentions the variety of Testosterone Replacement Therapy product applications, Testosterone Replacement Therapy statistics during 2015 to 2019.

Part number twelve, thirteen, fourteen and fifteen provides information regarding the futuristic Testosterone Replacement Therapy market trends expected during the forecast period from 2020 to 2024, Testosterone Replacement Therapy marketing strategies, Testosterone Replacement Therapy market vendors, facts and figures of the Testosterone Replacement Therapy market and vital Testosterone Replacement Therapy business conclusion along with data collection sources and appendix.

What Testosterone Replacement Therapy Market Report Contributes?

View Full Table Of Content: @

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

Continue reading here:
Global Testosterone Replacement Therapy Market 2020 Industry by Type, by Application, by Share, by Revenue and by Region Forecast to 2024 -...

Testosterone Replacement Therapy Market Report: Price, New Entrants SWOT Analysis, Competitive Landscape and Gross Margin Forecasted by 2027, Analysis…

Posted: November 3, 2020 at 8:58 am

The Global Testosterone Replacement Therapy Market report, published by Reports and Data, is an extensive compilation of the essential aspects of the global Testosterone Replacement Therapy market, assessed thoroughly by our team of researchers. The market intelligence report offers insightful data and information relevant to the market to acquaint the readers with the lucrative growth prospects existing in this industry, eventually helping them formulate effective business strategies. The global Testosterone Replacement Therapy market report has been methodically curated using industry-verified data to offer information concerned with the leading manufacturers and suppliers engaged in this sector. It further focuses on their pricing analysis, gross revenue, product portfolio, sales network & distribution channels, profit margins, and financial standing.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/229

Competitive Landscape:

The global Testosterone Replacement Therapy market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graphs, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market. Moreover, it highlights the strategic approaches of the key players towards expanding their product offerings and reinforcing their market presence.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

The report further sheds light on the various strategic business initiatives undertaken by the key market contenders to fortify their foothold in this business sector. These strategies majorly include mergers & acquisitions, partnerships & collaborations, joint ventures, government and corporate deals, brand promotions, new product launches, and numerous others. In the later part of the report, the major components of the Testosterone Replacement Therapy industry, such as product type, application gamut, end-use industries, and the solutions and services offered by the leading manufacturers, have been analyzed. Numerical data and subjective information pertaining to each market segment have been featured in the report for better understanding.

Therefore, the latest research document includes competitive analysis, key market players, crucial industry-related facts & figures, sales revenue, product prices, gross margins, market shares, business strategies, dominant regions, and key developments.

In market segmentation by types of Testosterone Replacement Therapy, the report covers-

In market segmentation by applications of the Testosterone Replacement Therapy, the report covers the following uses-

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/229

The report encompasses the significant effects of the coronavirus pandemic on the Testosterone Replacement Therapy market and its key segments. The report offers a vivid picture of the current market scenario, closely investigating the impact of the pandemic on this specific business sphere, its leading players, supply chains, distribution channels, and its global scenario. The pandemic has affected the global industry extensively, subsequently disrupting the Testosterone Replacement Therapy market mechanism. Furthermore, the research study examines the Testosterone Replacement Therapy market and the recent disruptive changes in the business setting that followed the outbreak. Also, the future effects of the pandemic on the market have been assessed in the report.

Key Geographies Encompassed in the Report:

Market Taxonomy:

Chapter 1: Methodology & Scope

Chapter 2: Executive Summary

Chapter 3: Industry Insights

Chapter 4: Regional Landscape

Chapter 5: Competitive Outlook

To read more about the report, visit @ https://www.reportsanddata.com/report-detail/global-testosterone-replacement-therapy-market-by-manufacturers-countries-type-and-application-forecast-to-2022

Advantages of the Testosterone Replacement Therapy Market Report:

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

Contact Us:

John Watson

Head of Business Development

Reports and Data|Web:www.reportsanddata.com

Direct Line:+1-212-710-1370

E-mail:[emailprotected]

Read this article:
Testosterone Replacement Therapy Market Report: Price, New Entrants SWOT Analysis, Competitive Landscape and Gross Margin Forecasted by 2027, Analysis...

The Male Menopause Treatment market to substantiate from 2019 to 2029 – TechnoWeekly

Posted: November 3, 2020 at 8:58 am

Male menopause refers to the hormonal imbalance or hormonal changes in the males due to which there is a reduction in the testosterone levels in the males. There are various symptoms of male menopause. Some of the symptoms include low energy, increasing body fat, decreasing bone density, erectile dysfunction, infertility, etc. There are many other changes associated with the testosterone level changes. Some of the major changes observed in males are a growth of the muscle mass, lowering of voice and changes related to sexual functioning. The male menopause can be treated by changing the lifestyle habits or it can be treated by taking testosterone replacement therapy. Healthy lifestyle habits such as taking a healthy diet. Having proper nap etc. can treat the male menopause treatment market.

Increasing research and developmental activities is one of the major factor driving the growth of male menopause treatment market. The rate of smoking is increasing, which can lead to hormonal imbalance, increasing the growth of the male menopause treatment market. Large intake of drugs and alcohol is another important factor, which can be responsible for the reduction of testosterone level and is expected to increase the growth of male menopause treatment market. Increasing adoption of poor lifestyle habits such as a high intake of junk food, lack of exercise, etc. can be responsible for increasing the growth of male menopause treatment market. Increasing stress due to daily hectic routine can also increase the growth of male menopause treatment market. Other factors, such as increasing healthcare awareness, technological advancements leading to better diagnostic rates, increasing disposable income, modernization of the Indian society, etc. can be responsible for the significant growth of male menopause treatment market.

There are various side effects of male menopause treatment drugs, which can hinder the growth of male menopause treatment market. Lack of awareness in some of the developing regions can restrain the growth of male menopause treatment market.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/28771

The global Male Menopause Treatment market is segmented on basis of drug type, Source of administration, distribution channel and geographic region:

Based on the drug type, the Male Menopause Treatment has been divided into testosterone supplements and vitamin supplements. Testosterone supplements can be given in various forms and are expected to hold the largest revenue share in the male menopause treatment market. Testosterone replacement therapy is the most common therapy, used for the treatment of male menopause treatment market. Amongst all the testosterone supplements, DHEA and D-Aspartic acid are expected to hold the maximum revenue share in the male menopause treatment market. Based on the route of administration, the male menopause treatment market has been divided into oral administration and subcutaneous administration. Oral route of administration is expected to hold the maximum revenue share in the male menopause treatment market as it is the most common form of administration used by the male patients. Based on the distribution channel, the male menopause treatment has been divided into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Drug stores and hospital pharmacies are expected to hold the maximum revenue share in the male menopause treatment market.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/28771

On the basis of geography, the global Male Menopause Treatment market is studied and divided into a few key regions such as North America, Latin America, Europe, Asia, Middle East & Africa and Oceania. North America is expected to hold a large revenue share in global Male Menopause Treatment market because of the presence of a large number of research and developmental activities and availability of technological advancement in the field of healthcare. Europe is expected to hold the second largest market share because of the presence of the large population. The Asia Pacific can also show a large revenue share in the Male Menopause Treatment market because of the increasing healthcare awareness

There are many companies manufacturing Male Menopause Treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Male Menopause Treatment drugs are Thermofisher Scientific Inc., Abbott, Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Bayer AG and many other companies.

You Can Request for TOC[emailprotected]

https://www.persistencemarketresearch.com/toc/28771

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

View post:
The Male Menopause Treatment market to substantiate from 2019 to 2029 - TechnoWeekly

Prison Is Even Worse When You Have a Disability Like Autism – The Marshall Project

Posted: November 3, 2020 at 8:58 am

When Drew Harrison was in prison, just sitting in his cell overloaded his senses. To dim the fluorescent lights, he covered the bulbs with toothpaste or paper. To mask overwhelming odors, he wrapped his uniform around his head.

Once, when he asked to stay longer in the prison yard, Harrison, who has autism, said he was told he was being insubordinate and was put in restrictive housing. Another time, he said he requested placement in solitary confinement so he wouldnt have to interact with people, which he found stressful.

After two and a half years, Harrison, who had been convicted of sexually assaulting an ex-girlfriend, thought he would get out more than a month early from Greensville Correction Center in Virginia, because of good behavior. But because he had failed to sign up for a job while incarcerated earlier at another Virginia prison, he had forfeited his chance at early release, according to documentation from the Virginia Department of Corrections.

Harrisons autism made it difficult for him to grasp the rules, his mother, Judy Harrison, explained. Only after she lobbied a Virginia state legislator was her sons good time reinstated; he was released in 2019. I dont know how someone with Drews diagnosis would have survived in prison without an advocate, she said. You cant teach someone not to have autism.

The prison environmentwith its loud, unpredictable noises, bright lights, unpleasant odors, complicated social dynamics and often byzantine bureaucracywould be difficult for anyone to navigate, but experts say that its particularly challenging for autistic people and people with similar disabilities.

The Americans with Disabilities Actsigned into law 30 years ago this summermandates that people with physical and developmental disorders receive equal access to programs and services provided by public institutions, including correctional facilities. But advocates for people with developmental disabilities have long argued that all too often, prisons do not fulfill that promise.

One reason may be that many states dont adequately identify prisoners with developmental disorders. The Marshall Project sent questions to all 50 state corrections departments asking whether and how they screen prisoners for developmental or intellectual disabilities. Of the 38 agencies that responded, 25 reported using screening protocols that several mental health and legal experts said dont meet professional standards. Five states said they dont screen for developmental disabilities at all.

When developmentally disabled prisoners go unidentified, they are even less likely to receive services they are entitled to under federal lawsuch as help understanding prison rules or obtaining medications. That loss of assistance leaves them vulnerable to medical misdiagnosis, isolation in solitary confinement, denial of legal and educational opportunities, sexual abuse and bullying, prisoner advocates and relatives say.

It mirrors or echoes what goes on in society. People with disabilities are often hidden and not seen, said Susan Politt, a supervising attorney at Disability Rights North Carolina, an advocacy agency. But behind bars, the situation can be even more dire. They get out in worse condition than when they go in, she said.

Experts say that incarcerated people of color with intellectual and developmental disabilities are affected disproportionately because they are less likely than their White counterparts to be diagnosed before they enter prison.

Developmental disability is an umbrella term for a group of disorders that start during childhood and restrict ones ability to learn, speak, behave or physically develop; they include autism, cerebral palsy and language and speech disorders. The most common type is intellectual disability. It is generally accepted that 2 to 3 percent of people around the world have an intellectual disability, said Maggie Nygren, executive director of American Association on Intellectual and Developmental Disabilities.

The proportion of people with developmental disabilities behind bars is likely to be higher than in the general population, research suggests. The Arc, a nonprofit that advocates for people with disabilities, estimates that between 4 and 10 percent of U.S. prisoners have an intellectual disability, a range supported by recent literature. In 2015, the Bureau of Justice Statistics reported that about 20 percent of prisoners mentioned having a cognitive disability, a category that includes developmental disability.

But when The Marshall Project contacted state corrections departments, only four of the 25 states that shared their 2019 numbers reported that the population of prisoners with developmental or intellectual disabilities was in that range. The other 21 states that shared their population numbers said that prisoners with developmental disabilities made up less than 4 percent of the total prison population.

One disability rights lawyer characterized those low numbers as implausible. Theres no rational basis under which a prison population should have a lower percentage than a general population, said Bill Van Der Pol, a senior staff attorney at the Alabama Disabilities Advocacy Project, who won a class-action lawsuit in 2014 on behalf of physically and developmentally disabled prisoners.

Thirteen states told The Marshall Project that they did not track the population numbers or could not provide them.

Many states are using screening protocols that medical and legal experts say are below professional standards. An exam should assess a persons intellect, capacity to participate in daily activities and the age at which their condition began, said Nygren. But 11 states said they either did not check for those three diagnostic points or didnt test for intellectual ability at all.

Several states said they rely primarily on an IQ test as a screening tool. In North Carolina, prisoners take an IQ test in a group upon entering the system. If they get a score of 70 or lessthe states cutoff for intellectual disabilityprisoners take the exam again. But this process prevents people with intellectual disability from being identified because it fosters familiarity with the exam, often resulting in higher scores, said John Schwade, a former prison psychologist in North Carolina who retired in 2016. Representatives from the North Carolina Department of Public Safety said that 1.8 percent of prisoners in 2019 tested with an IQ of 70 or less, well below the expected percentage.

According to a document obtained by The Marshall Project, one prisoner scored 60 on the states IQ test when first taking it, suggesting a serious intellectual disability. But after sitting for the same test again a few days later, the prisoner scored 83, which is in the normal range.

The screenings for intellectual disability are not designed to identify and provide help to inmates, but instead to exclude as many inmates as possible from receiving the help they need, Schwade wrote in an email. The consequence for disabled prisoners in the state has been a total failure to accommodate and protect, said Politt from Disability Rights North Carolina.

John Bull, the communications officer for prisons at the North Carolina Department of Public Safety, said the states strategy allows officials to quickly identify prisoners with disabilities without wasting time on those who dont need extra help. Prisons are very short-staffed, he said.

Of the other states that test prisoners during screening, eightMassachusetts, South Dakota, North Dakota, New Hampshire, Iowa, Texas, Utah, and Idahosaid they use the Test of Adult Basic Education, which is designed to evaluate academic achievement, not IQ. Experts say the exam could give hints about a persons disability, but it isnt designed to identify developmental disabilities.

Officials in five other statesKentucky, Maine, Virginia, New Mexico, and Delawaresaid their agencies dont use a test to screen prisoners for developmental disorders. In Kentucky and Virginia, officials said they typically leave it up to prisoners to tell the staff about their own disabilities. In Maine, for the most part clinicians estimate a general intellectual level of below average, average or above average, the deputy commissioner of corrections said. In New Mexico and Delaware, officials said they rely on medical and educational records to identify people who were diagnosed with a disability or participated in special education programming before entering the prison system.

Anne Morel, whose 37-year-old son David is serving time in Louisiana for possession of child pornography, said prison officials have no clue that he is mentally challenged. David was first diagnosed with intellectual disability at age 6, she said. At 25, he was told he had an IQ of 63.

David often gets scammed, his mother said, by prisoners who persuade him to buy them things with the money she gives him for food. She also believes that her son has been taken advantage of sexually. Anything anyone would tell him, Morel said, he would just do.

Autistic people and people with intellectual disability often have difficulty understanding prison rules and norms, making them especially vulnerable to exploitation in prison, says Jamelia Morgan, an associate professor at the University of Connecticut School of Law. Theres disproportionate exposure to violence, sexual or otherwise, she added.

Some parents of incarcerated people with developmental disorders say they feel powerless to help their children cope behind bars.

Gary Glissman of Nebraska said that when his adult son, Michael, spent three months in an Omaha jail for theft, he submitted medical documentation to health officials demonstrating that Michael had a clinical need for testosterone replacement therapy and psychological counseling.

Michael suffers from depression and anxiety related to Klinefelter Syndrome, a genetic developmental disability that can lead to abnormally low levels of testosterone and difficulty controlling emotions in moments of stress.

Glissman says he wasnt surprised that officials werent responsive. Its very basic in the prison system, he said. Either its broken or bleeding, or too bad.

Correction: A previous version of this story misstated the Virginia state prison where Drew Harrison was incarcerated when he learned that he was no longer eligible for early release.

Originally posted here:
Prison Is Even Worse When You Have a Disability Like Autism - The Marshall Project

The Male Hypogonadism Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ 3300 Mn – The Think Curiouser

Posted: November 3, 2020 at 8:58 am

Market Report Summary

For Full Information -> Click Here

Read Full Press Release Below

According to Persistence Market Researchs new report, globalmale hypogonadism marketis slated to exhibit a steady expansion throughout the forecast period (2017-2026). Revenues from the global market for male hypogonadism are estimated to exceed US$ 3,300 Mn by 2026-end.

Governments Taking Initiatives to Spread Awareness about Male Hypogonadism Therapeutics

Lack of sex hormones, usually referred to as male hypogonadism has resulted into many health risks that include osteoporosis, heart disease, and cardiovascular diseases on the back of thinning of bones. Global male hypogonadism market comprises several patented brands that currently have high market penetration. Proliferation in geriatric population in tandem with rising incidences related to rheumatoid arthritis and obesity have been primary factors affecting prevalence of male hypogonadism globally.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/22303

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/22303

Mounting incidences of testosterone deficiency in male population is a key factor that prevalence of male hypogonadism has surged worldwide. Several governments around the world have been taking initiatives to spread the awareness on hypogonadism treatment procedures, for example testosterone replacement therapy (TST), in order to relieve the painful burden on patients and their families.

As low testosterone levels are increasingly associated with exacerbation of chronic conditions, it further results into disorders apropos to hypothalamic-pituitary-gonadal axis. Advent of TST has however enabled reduction in cases of male hypogonadism considerably. With growing awareness related to its treatment among patients, the market is likely to gain an uptick during the forecast period.

Rising availability of the selective androgen receptor modulators (SARMs) has further sustained the market expansion. The development and high availability of SARMs has led toward the provision of improved treatment procedure to patients having androgen deficiencies, thereby influencing the market growth.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/22303

North America will continue to Dominate Global Male Hypogonadism Market

North America will continue to dominate the global male hypogonadism market, with more than one-third revenue share during the forecast period. In addition, revenues from the male hypogonadism market in North America will exhibit the fastest expansion through 2026, as compared to those from all the other regional segments comprised in the report. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative for the male hypogonadism market. The market in APEJ will ride on a slightly higher CAGR than that in Europe through 2026.

Topical gels are expected to remain the most lucrative among drugs available for treatment of male hypogonadism globally, with sales projected to register the fastest expansion through 2026. Injectables will also remain a major revenue contributor to the market. Sales of injectable and transdermal patches are poised to reflect an equal CAGR through 2026.

Testosterone Replacement Therapy to Remain Preferred among Patients

Based on therapy, testosterone replacement therapy is expected to remain preferred among patients with male hypogonadism worldwide. Roughly 66% revenue share of the market is expected to be held by revenues from testosterone replacement therapy by 2026-end. Revenues from gonadotropin replacement therapy will remain slightly more than half revenues gained from testosterone replacement therapy throughout the forecast period.

Klinefelters syndrome is expected to remain the most prevalent disease type observed in the male hypogonadism market, and revenues from treatment of this disease will exceed US$ 1,800 Mn by 2026-end. Kallmann Syndrome and Pituitary Adenomas among disease types will also account for major revenue shares of the market by 2026-end.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Read more:
The Male Hypogonadism Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ 3300 Mn - The Think Curiouser


Page 434«..1020..433434435436..440450..»